Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Evaluation of the iodoacetic acid effects on adipose-derived mesenchymal stem cells and alteration of their osteogenic differentiation potential by inducing oxidative stress.

Noghlebari NA., Hajarizadeh A., MohammadEbrahim N., H M., Abbot V., Pramanik A.

Laboratory Study on Hip, published in Naunyn Schmiedebergs Arch Pharmacol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Naunyn Schmiedebergs Arch Pharmacol (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
39994069
DOI
10.1007/s00210-025-03870-0

Abstract (original English)

Drinking water disinfection byproducts (DBPs) can adversely affect human health. Iodoacetic acid (IAA) is a DBP associated with most cytotoxic, genotoxic, and mutagenic disorders. However, its effects on the osteogenic differentiation of adipose-derived mesenchymal stem cells, ADMSCs, remain unknown. In this study, the cytotoxicity, cytokine response, phenotype, and osteogenic differentiation potential of the ADMSCs were evaluated in the presence and absence of IAA. It was revealed that IAA induces a toxic response at a concentration of 2 µM. Flow cytometry confirmed no significant alterations in ADMSCs' phenotype after treatment with 10 nM and 1 µM IAA for 48 h. IAA led to a decreased secretion of IL-8, a dose-dependent secretion of IL-10, and no significant change in the secretion of IL-6 compared to the control group. The osteogenic differentiation ability of ADMSCs in the presence of different concentrations and exposure times to IAA was evaluated by measurement of alkaline phosphatase activity, calcium content, Alizarin Red S, real-time PCR, and immunocytochemistry assays. The findings show that the osteogenic differentiation of ADMSCs decreased at higher concentrations of IAA and extended exposure time, confirming the potential disruption of the osteogenic differentiation of ADMSCs.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Mesenchymal Stem CellsOsteogenesisCell DifferentiationHumansOxidative StressIodoacetic AcidAdipose TissueCells, CulturedDose-Response Relationship, DrugAlkaline Phosphatase

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research